Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CHH NYSE:KSS NASDAQ:TGTX NASDAQ:UPST On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHHChoice Hotels International$113.57+0.4%$108.35$84.04▼$136.45$5.15B0.65671,193 shs671,826 shsKSSKohl's$13.20+1.1%$13.36$7.61▼$25.22$1.47B1.464.26 million shs5.29 million shsTGTXTG Therapeutics$39.73+2.2%$35.70$25.28▼$44.65$5.95B1.682.16 million shs1.29 million shsUPSTUpstart$30.62+7.2%$28.89$23.97▼$87.30$2.93B2.264.74 million shs5.84 million shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHHChoice Hotels International+0.26%+7.01%-4.49%+5.79%-11.66%KSSKohl's+0.93%+12.63%-10.51%-23.05%+76.47%TGTXTG Therapeutics+2.21%+0.76%+8.49%+33.95%+14.93%UPSTUpstart+7.21%+9.05%-8.57%+7.67%-32.35%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHHChoice Hotels International$113.57+0.4%$108.35$84.04▼$136.45$5.15B0.65671,193 shs671,826 shsKSSKohl's$13.20+1.1%$13.36$7.61▼$25.22$1.47B1.464.26 million shs5.29 million shsTGTXTG Therapeutics$39.73+2.2%$35.70$25.28▼$44.65$5.95B1.682.16 million shs1.29 million shsUPSTUpstart$30.62+7.2%$28.89$23.97▼$87.30$2.93B2.264.74 million shs5.84 million shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHHChoice Hotels International+0.26%+7.01%-4.49%+5.79%-11.66%KSSKohl's+0.93%+12.63%-10.51%-23.05%+76.47%TGTXTG Therapeutics+2.21%+0.76%+8.49%+33.95%+14.93%UPSTUpstart+7.21%+9.05%-8.57%+7.67%-32.35%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHHChoice Hotels International 1.86Reduce$111.67-1.68% DownsideKSSKohl's 1.75Reduce$14.7711.89% UpsideTGTXTG Therapeutics 2.57Moderate Buy$52.5032.14% UpsideUPSTUpstart 2.25Hold$45.7949.53% UpsideCurrent Analyst Ratings BreakdownLatest CHH, TGTX, KSS, and UPST Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/26/2026CHHChoice Hotels International Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$129.00 ➝ $128.005/15/2026KSSKohl's Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy5/15/2026KSSKohl's Gordon HaskettSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold$14.005/12/2026CHHChoice Hotels International Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetUnderweight$87.00 ➝ $86.005/11/2026CHHChoice Hotels International Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$128.005/8/2026UPSTUpstart MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$45.005/7/2026UPSTUpstart Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$35.005/6/2026UPSTUpstart Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D+) ➝ Sell (D)5/6/2026TGTXTG Therapeutics HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$60.00 ➝ $70.005/6/2026UPSTUpstart Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$40.005/6/2026UPSTUpstart Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$56.00 ➝ $46.00(Data available from 5/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHHChoice Hotels International$1.60B3.22$9.48 per share11.98$3.02 per share37.61KSSKohl's$15.53B0.10$8.00 per share1.65$36.08 per share0.37TGTXTG Therapeutics$700.35M8.68$2.86 per share13.87$3.81 per share10.43UPSTUpstart$1.12B2.62$0.86 per share35.42$7.66 per share4.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHHChoice Hotels International$369.95M$7.4215.3114.452.0821.55%281.98%10.90%8/5/2026 (Estimated)KSSKohl's$272M$2.365.599.36N/A1.75%4.72%1.36%5/28/2026 (Estimated)TGTXTG Therapeutics$447.18M$2.8613.8914.29N/A65.95%88.73%43.44%8/3/2026 (Estimated)UPSTUpstart$53.60M$0.3880.5818.010.774.34%5.63%1.49%8/4/2026 (Estimated)Latest CHH, TGTX, KSS, and UPST EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/28/2026Q1 2027KSSKohl's-$0.18N/AN/AN/A$2.99 billionN/A5/6/2026Q1 2026TGTXTG Therapeutics$0.23$0.12-$0.11$0.12$200.33 million$204.92 million5/5/2026Q1 2026UPSTUpstart$0.39-$0.07-$0.46-$0.07$301.30 million$308.21 million4/30/2026Q1 2026CHHChoice Hotels International$1.35$1.07-$0.28$0.44$333.48 million$340.58 million3/10/2026Q4 2026KSSKohl's$0.86$1.07+$0.21$1.07$5.08 billion$5.17 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCHHChoice Hotels International$1.151.01%+37.97%15.50%N/AKSSKohl's$0.503.79%-6.51%21.19%N/ATGTXTG TherapeuticsN/AN/AN/AN/AN/AUPSTUpstartN/AN/AN/AN/AN/ALatest CHH, TGTX, KSS, and UPST DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/20/2026CHHChoice Hotels Internationalquarterly$0.28751.02%7/1/20267/1/20267/15/20265/20/2026KSSKohl'squarterly$0.12504.09%6/10/20266/10/20266/24/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHHChoice Hotels International14.580.950.95KSSKohl's0.941.460.37TGTXTG Therapeutics1.285.815.12UPSTUpstartN/A0.490.49Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHHChoice Hotels International65.57%KSSKohl's98.04%TGTXTG Therapeutics58.58%UPSTUpstart63.01%Insider OwnershipCompanyInsider OwnershipCHHChoice Hotels International24.02%KSSKohl's1.55%TGTXTG Therapeutics10.64%UPSTUpstart17.29%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHHChoice Hotels International1,70045.50 million34.68 millionOptionableKSSKohl's84,000112.25 million110.51 millionOptionableTGTXTG Therapeutics290153.08 million136.80 millionOptionableUPSTUpstart1,40595.71 million79.16 millionOptionableCHH, TGTX, KSS, and UPST HeadlinesRecent News About These CompaniesSHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Upstart Holdings, Inc. (UPST)23 minutes ago | globenewswire.comUpstart Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - UPSTMay 27 at 2:06 AM | prnewswire.comUPST Investors Have Opportunity to Lead Upstart Holdings, Inc. Securities Fraud Lawsuit with the Schall Law FirmMay 27 at 2:01 AM | prnewswire.comUPST EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Upstart (UPST) Investors of Securities Class Action Deadline on June 8, 2026May 26 at 6:22 PM | newsfilecorp.comNPomerantz Law Firm Announces the Filing of a Class Action Against Upstart Holdings, Inc.and Certain Officers – UPSTMay 26 at 3:55 PM | globenewswire.comROSEN, LEADING INVESTOR COUNSEL, Encourages Upstart Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 8 Deadline in Securities Class Action - UPSTMay 26 at 1:08 PM | newsfilecorp.comNBronstein, Gewirtz & Grossman LLC Urges Upstart Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor HarmMay 26 at 12:00 PM | newsfilecorp.comNUPSTART HOLDINGS, INC. (UPST) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by June 8, 2026May 26 at 9:11 AM | newsfilecorp.comNPortnoy Law Firm Announces Class Action on Behalf of Upstart Holdings, Inc. InvestorsMay 26 at 9:05 AM | globenewswire.comThe Gross Law Firm Reminds Upstart, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of June 8, 2026 - UPSTMay 26 at 9:00 AM | prnewswire.comBronstein, Gewirtz & Grossman LLC Urges Upstart Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor HarmMay 25 at 12:00 PM | globenewswire.comUPST Investors Have Opportunity to Lead Upstart Holdings, Inc. Securities Fraud Lawsuit with the Schall Law FirmMay 25 at 11:11 AM | globenewswire.comUpstart (NASDAQ:UPST) Insider Sells $15,133.02 in StockMay 25 at 5:19 AM | americanbankingnews.comA Western Auto Giant Found a Lifeline: Working With a Chinese UpstartMay 24 at 9:00 PM | wsj.comROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Upstart Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – UPSTMay 24 at 7:39 PM | globenewswire.comUPST UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Upstart (UPST) Investors of Securities Class Action Deadline on June 8, 2026May 24 at 3:20 PM | newsfilecorp.comNUpstart (UPST) Appoints Tim Wennes to Board of Directors, Succeeding Jeff HuberMay 23, 2026 | finance.yahoo.comUPST SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Upstart (UPST) Investors of Securities Class Action Deadline on June 8, 2026May 23, 2026 | newsfilecorp.comNNatalia Mirgorodskaya Sells 526 Shares of Upstart (NASDAQ:UPST) StockMay 23, 2026 | insidertrades.comNatalia Mirgorodskaya Sells 526 Shares of Upstart (NASDAQ:UPST) StockMay 22, 2026 | marketbeat.comInsider Selling: Upstart (NASDAQ:UPST) Insider Sells $229,728.45 in StockMay 22, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It LaunchesBy Bridget Bennett | May 4, 2026Apple Talks Just Changed Everything for IntelBy Sam Quirke | May 6, 20263 Energy Stocks to Buy and 2 to Avoid as AI Power Demand ExplodesBy Bridget Bennett | May 4, 2026Alphabet’s Earnings Didn’t Just Beat—They Changed the StoryBy Ryan Hasson | April 30, 2026Insider Buying Says Upstart Isn’t Down for the CountBy Thomas Hughes | May 18, 2026CHH, TGTX, KSS, and UPST Company DescriptionsChoice Hotels International NYSE:CHH$113.57 +0.45 (+0.40%) Closing price 05/26/2026 03:58 PM EasternExtended Trading$113.71 +0.14 (+0.12%) As of 08:43 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Choice Hotels International, Inc., together with its subsidiaries, operates as a hotel franchisor in the United States and internationally. It operates through Hotel Franchising & Management and Corporate & Other segments. The company franchises lodging properties under the brand names of Comfort Inn, Comfort Suites, Quality, Clarion, Clarion Pointe, Sleep Inn, Ascend Hotel Collection, Econo Lodge, Rodeway Inn, MainStay Suites, Suburban Studios, WoodSpring Suites, Everhome Suites, Cambria Hotels, Radisson Blu, Radisson RED, Radisson, Park Plaza, Country Inn & Suites by Radisson, Radisson Inn & Suites, Park Inn by Radisson, Radisson Individuals, and Radisson Collection. Choice Hotels International, Inc. was founded in 1939 and is headquartered in North Bethesda, Maryland.Kohl's NYSE:KSS$13.20 +0.14 (+1.07%) Closing price 05/26/2026 03:58 PM EasternExtended Trading$13.41 +0.21 (+1.59%) As of 08:48 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Kohl's Corporation operates as an omnichannel retailer in the United States. It offers branded apparel, footwear, accessories, beauty, and home products through its stores and website. The company provides its products primarily under the brand names of Croft & Barrow, Jumping Beans, SO, Sonoma Goods for Life, and Tek Gear, as well as Food Network, LC Lauren Conrad, Nine West, and Simply Vera Vera Wang. Kohl's Corporation was founded in 1988 and is headquartered in Menomonee Falls, Wisconsin.TG Therapeutics NASDAQ:TGTX$39.73 +0.86 (+2.21%) Closing price 05/26/2026 04:00 PM EasternExtended Trading$40.38 +0.65 (+1.62%) As of 08:54 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Umbralisib, an oral inhibitor of PI3K-delta inhibitor for the treatment of adult patients with relapsed or refractory marginal zone lymphoma and follicular lymphoma; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; Rhizen Pharmaceuticals, S A. for the development and commercialization of umbralisib; Jiangsu Hengrui Medicine Co.; and Novimmune SA, as well as collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. TG Therapeutics, Inc. was incorporated in 1993 and is based in Morrisville, North Carolina.Upstart NASDAQ:UPST$30.62 +2.06 (+7.21%) Closing price 05/26/2026 04:00 PM EasternExtended Trading$30.98 +0.36 (+1.17%) As of 08:58 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Upstart Holdings, Inc., together with its subsidiaries, operates a cloud-based artificial intelligence (AI) lending platform in the United States. Its platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small dollar loans that connects consumer demand for loans to its to bank and credit unions. Upstart Holdings, Inc. was founded in 2012 and is headquartered in San Mateo, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AutoZone's Pullback Sets Up a Long-Term Buying Opportunity AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus Powerhouse Williams-Sonoma Heading to Fresh Highs in 2026 Quantum Stocks Just Got a Lifeline—Who Benefits Most? Why BJ’s Wholesale Club Stock Could Be Ready for a Rebound 5 High-Yield Stocks and ETFs to Buy and Hold for the Next Decade Rocket Companies Turns Around, But Mortgage Risk Remains After NVIDIA, Broadcom's Earnings Are Next—Here's What to Watch Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
